KEY FEATURES
Full Name | Leukemia Inhibitory Factor Receptor |
---|---|
Synonym | CD118; SJS2; STWS; SWS |
Assay Type | Sandwich |
Reactivity | Human |
Range | 0.31-20ng/mL |
Sensitivity | 0.12ng/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human LIFR in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human LIFR. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human LIFR and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human LIFR, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human LIFR. You can calculate the concentration of Human LIFR in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human LIFR ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (ng/mL) | 0.94 | 2.8 | 9.6 | 0.94 | 2.76 | 9.75 |
Standard deviation | 0.06 | 0.16 | 0.3 | 0.05 | 0.13 | 0.47 |
CV(%) | 6.55 | 5.58 | 3.09 | 5.77 | 4.8 | 4.77 |
RECOVERY
The recovery of Human LIFR spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 89-102 | 96 |
EDTA plasma (n=8) | 89-106 | 97 |
Cell culture media (n=8) | 91-105 | 96 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human LIFR in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with LIFR ELISA Kits
LIF ELISA Kit | publications with LIFR and LIF |
OSM ELISA Kit | publications with LIFR and OSM |
CNTF ELISA Kit | publications with LIFR and CNTF |
IL6ST ELISA Kit | publications with LIFR and IL6ST |
STAT3 ELISA Kit | publications with LIFR and STAT3 |
CNTFR ELISA Kit | publications with LIFR and CNTFR |
JAK2 ELISA Kit | publications with LIFR and JAK2 |
PTPN6 ELISA Kit | publications with LIFR and PTPN6 |
Pathways associated with LIFR ELISA Kit
Adipogenesis Pathway | Adipogenesis Pathway |
Cytokine-cytokine Receptor Interaction Pathway | Cytokine-cytokine Receptor Interaction Pathway |
Jak-STAT Signaling Pathway | Jak-STAT Signaling Pathway |
Oncostatin M Signaling Pathway | Oncostatin M Signaling Pathway |
Physiological And Pathological Hypertrophy Of The Heart Pathway | Physiological And Pathological Hypertrophy Of The Heart Pathway |
Signaling Pathways Regulating Pluripotency Of Stem Cells | Signaling Pathways Regulating Pluripotency Of Stem Cells |
Diseases associated with LIFR ELISA Kit
Nervous System Diseases | publications with LIFR and Nervous System Diseases |
Inflammation | publications with LIFR and Inflammation |
Cardiovascular Diseases | publications with LIFR and Cardiovascular Diseases |
Disease Models, Animal | publications with LIFR and Disease Models, Animal |
Necrosis | publications with LIFR and Necrosis |
Liver Diseases | publications with LIFR and Liver Diseases |
Hypertrophy | publications with LIFR and Hypertrophy |
Adenocarcinoma | publications with LIFR and Adenocarcinoma |
Heart Diseases | publications with LIFR and Heart Diseases |
Stuve-Wiedemann syndrome | publications with LIFR and Stuve-Wiedemann syndrome |
Organs/Tissues associated with LIFR ELISA Kit
Nerve | publications with LIFR and Nerve |
Brain | publications with LIFR and Brain |
Uterus | publications with LIFR and Uterus |
Embryonic Tissue | publications with LIFR and Embryonic Tissue |
Muscle | publications with LIFR and Muscle |
Liver | publications with LIFR and Liver |
Placenta | publications with LIFR and Placenta |
Heart | publications with LIFR and Heart |
Vascular | publications with LIFR and Vascular |
Ganglia | publications with LIFR and Ganglia |